GL9 Stock Overview
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Glanbia plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €17.50 |
| 52 Week High | €18.38 |
| 52 Week Low | €12.43 |
| Beta | 0.55 |
| 1 Month Change | 1.63% |
| 3 Month Change | 19.70% |
| 1 Year Change | 37.36% |
| 3 Year Change | 42.97% |
| 5 Year Change | 11.39% |
| Change since IPO | 61.66% |
Recent News & Updates
Recent updates
Shareholder Returns
| GL9 | DE Food | DE Market | |
|---|---|---|---|
| 7D | 3.4% | -1.0% | 0.5% |
| 1Y | 37.4% | -23.9% | 1.3% |
Return vs Industry: GL9 exceeded the German Food industry which returned -24.5% over the past year.
Return vs Market: GL9 exceeded the German Market which returned 2.3% over the past year.
Price Volatility
| GL9 volatility | |
|---|---|
| GL9 Average Weekly Movement | 7.9% |
| Food Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: GL9 has not had significant price volatility in the past 3 months.
Volatility Over Time: GL9's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1964 | 5,534 | Hugh McGuire | www.glanbia.com |
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, ready-to-eat bars and snacking food, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products.
Glanbia plc Fundamentals Summary
| GL9 fundamental statistics | |
|---|---|
| Market cap | €4.62b |
| Earnings (TTM) | €324.03m |
| Revenue (TTM) | €5.06b |
14.3x
P/E Ratio0.9x
P/S RatioIs GL9 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GL9 income statement (TTM) | |
|---|---|
| Revenue | US$5.43b |
| Cost of Revenue | US$4.30b |
| Gross Profit | US$1.12b |
| Other Expenses | US$776.50m |
| Earnings | US$347.60m |
Last Reported Earnings
Dec 30, 2023
Next Earnings Date
Aug 14, 2024
| Earnings per share (EPS) | 1.33 |
| Gross Margin | 20.72% |
| Net Profit Margin | 6.41% |
| Debt/Equity Ratio | 31.1% |
How did GL9 perform over the long term?
See historical performance and comparison